← back to search

Alexandre Bejanin

Hospital de Sant Pau ·
Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Down syndrome and intellectual disability research, and Functional Brain Connectivity Studies.
h-index
34
citations
5,803
works
213
NIH funding
primary concept
Psychology
email

Recent publications

Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages
Neurology 2025cited by 11position: middledoi
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
JAMA Neurology 2024cited by 329position: middledoi
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
Nature Medicine 2024cited by 311position: middledoi
Multimodal neuroimaging correlates of spectral power in NREM sleep delta sub-bands in cognitively unimpaired older adults
SLEEP 2024cited by 9position: middledoi
Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome
Brain Communications 2023cited by 60position: middledoi
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study
EBioMedicine 2023cited by 55position: middledoi
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome
Alzheimer s & Dementia 2023cited by 30position: middledoi
Dynamic functional connectivity patterns associated with dementia risk
Alzheimer s Research & Therapy 2022cited by 32position: middledoi
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
The Lancet Neurology 2021cited by 993position: middledoi
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
JAMA Neurology 2021cited by 78position: firstdoi
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome
Nature Communications 2021cited by 71position: middledoi
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
Alzheimer s Research & Therapy 2019cited by 162position: middledoi
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Brain 2017cited by 782position: firstdoi
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
NeuroImage Clinical 2017cited by 166position: middledoi
Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer's disease
Neurobiology of Aging 2017cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gil D. Rabinovici · Harvard University4 papers (2017–2021)Mustafa Janabi · University of California, Berkeley3 papers (2017–2019)James P. O’Neil · University of California, Berkeley3 papers (2017–2019)Maria Luisa Gorno‐Tempini · University Memory and Aging Center3 papers (2017–2019)Bruce L. Miller · University at Buffalo, State University of New York3 papers (2017–2019)William J. Jagust · Berkeley College3 papers (2017–2019)Suzanne L. Baker · Lawrence Berkeley National Laboratory3 papers (2017–2019)Howard J. Rosen · Medical University of South Carolina3 papers (2017–2019)Renaud La Joie · University Memory and Aging Center2 papers (2017–2017)Daniel R. Schonhaut · University of California, San Francisco2 papers (2017–2017)Adam L. Boxer · Brunel University of London2 papers (2017–2019)Joel H. Kramer · Cisco Systems (United States)2 papers (2017–2017)Zachary Miller · University Memory and Aging Center2 papers (2017–2017)Nagehan Ayakta · Stanford University2 papers (2017–2017)Orit H. Lesman‐Segev · Tel Aviv University1 papers (2019–2019)Daniel Alcolea · Hospital de Sant Pau1 papers (2024–2024)Agneta Nordberg · Karolinska University Hospital1 papers (2021–2021)Stéphane Epelbaum · Eli Lilly (United States)1 papers (2021–2021)Andreas Lazaris · Brown University1 papers (2017–2017)Richard Tsai · Denali Therapeutics (United States)1 papers (2019–2019)